We are live on ! Find out more
VASC

Vascular Solutions Inc
VASC

Delisted

VASC was delisted on the 17th of February, 2017.

143 hedge funds and large institutions have $444M invested in Vascular Solutions Inc in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 59 increasing their positions, 43 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

37% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 43

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

6% more capital invested

Capital invested by funds: $420M → $444M (+$24.2M)

1% more funds holding

Funds holding: 141143 (+2)

97% less call options, than puts

Call options by funds: $55K | Put options by funds: $2.19M

Holders
143
Holders Change
+2
Holders Change %
+1.42%
% of All Funds
3.75%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
16
Increased
59
Reduced
43
Closed
12
Calls
$55K
Puts
$2.19M
Net Calls
-$2.14M
Net Calls Change
-$632K
Name Holding Trade Value Shares
Change
Change in
Stake
DADC
126
D.A. Davidson & Co
Montana
$39K +$2.54K +75 +7%
EARNEST Partners
127
EARNEST Partners
Georgia
$38K
Citigroup
128
Citigroup
New York
$38K +$136 +4 +0.4%
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
$35K +$25.2K +744 +267%
TDC
130
Thompson Davis & Co
Virginia
$26K -$289K -8,530 -92%
MFS
131
MSI Financial Services
Massachusetts
$26K
LIA
132
LS Investment Advisors
Michigan
$23K +$1.97K +58 +10%
US Bancorp
133
US Bancorp
Minnesota
$21K
BlackRock
134
BlackRock
New York
$20K +$6.2K +183 +46%
BIM
135
Barton Investment Management
Pennsylvania
$14K +$14.1K +415 New
TRCT
136
Tower Research Capital (TRC)
New York
$12K +$11.5K +339 New
PCM
137
Prelude Capital Management
New York
$7K -$156K -4,610 -96%
CF
138
CenterStar Fund
Illinois
$7K
Creative Planning
139
Creative Planning
Kansas
$7K
Manulife (Manufacturers Life Insurance)
140
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.36K +$808K +23,839 +32%
Federated Hermes
141
Federated Hermes
Pennsylvania
$2K -$998K -29,462 -100%
Fifth Third Bancorp
142
Fifth Third Bancorp
Ohio
$2K +$34 +1 +2%
MDCM
143
Morgan Dempsey Capital Management
Wisconsin
$1K +$1.42K +42 New
Millennium Management
144
Millennium Management
New York
-$1.79M -55,393 Closed
BIM
145
Bogle Investment Management
Massachusetts
-$1.27M -39,230 Closed
TI
146
Turner Investments
Pennsylvania
-$1.13M -35,000 Closed
BMCMI
147
Bryn Mawr Capital Management Inc
Pennsylvania
-$573K -17,691 Closed
SEI Investments
148
SEI Investments
Pennsylvania
-$512K -15,794 Closed
OAM
149
Oberweis Asset Management
Illinois
-$395K -12,186 Closed
CCMH
150
Cornerstone Capital Management Holdings
New York
-$347K -10,700 Closed

VASC Hedge Fund Activity: Q4 2015 in Review

143 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Vascular Solutions Inc (VASC) for Q4 2015, worth a combined $444M — up 5.8% from $420M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new VASC positions and 12 closed out — a net gain of 4 holders — while 59 added to existing stakes and 43 trimmed.

The largest buyer was Conestoga Capital Advisors, adding an estimated $4.66M. The largest seller was Granahan Investment Management, cutting an estimated $3.3M.

  • 143 institutional investors held Vascular Solutions Inc (VASC) as of Q4 2015, up from 141 in Q3 2015.
  • Funds reported $444M of Vascular Solutions Inc stock for Q4 2015, up 5.8% quarter-over-quarter.
  • 16 funds opened new Vascular Solutions Inc positions in Q4 2015 and 12 closed out, a net change of +4 holders.
  • The largest Vascular Solutions Inc buyer in Q4 2015 was Conestoga Capital Advisors, an estimated $4.66M added.
  • The largest Vascular Solutions Inc seller in Q4 2015 was Granahan Investment Management, an estimated $3.3M sold.

Based on aggregated 13F filings for Q4 2015.